Aeropace Neurostimulation Console
Payments companies reported to CMS as associated with Aeropace Neurostimulation Console. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Aeropace Neurostimulation Console, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Aeropace Neurostimulation Console
These are the largest totals companies reported as associated with Aeropace Neurostimulation Console. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Ali Ataya | Gainesville, FL | Critical Care Medicine (Internal Medicine) | $5,725.00 |
| Joseph Shrager | Palo Alto, CA | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $2,500.00 |
| Dustin Fraidenburg | Chicago, IL | Pulmonary Disease | $437.50 |
| Andrew Holt | Memphis, TN | Pulmonary Disease | $174.28 |
| Anthony Mattox | Memphis, TN | Critical Care Medicine (Internal Medicine) | $174.28 |
| David Williams | Memphis, TN | Critical Care Medicine (Internal Medicine) | $174.28 |
| Kimberly Marsh | Memphis, TN | Critical Care Medicine (Internal Medicine) | $174.28 |
| Steven Woods | Memphis, TN | Critical Care Medicine (Internal Medicine) | $174.28 |
| Crystal Stanton | Memphis, TN | Critical Care Medicine (Internal Medicine) | $174.28 |
| Hayley Gershengorn | Miami, FL | Pulmonary Disease | $116.37 |
Prescribed Aeropace Neurostimulation Console?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.